000403 派林生物
按盤價 
10.040 +0.090 (+0.905%)
10.040 +0.090 (+0.905%) | 2026/06 - 中期 (K) | 2025/12 (K) | 2024/12 (K) | 2023/12 (K) | 2022/12 (K) | |
| 經營活動產生之現金流量淨額 | (83,872) | (215,991) | 321,790 | 679,006 | 524,219 |
| 投資活動產生之現金流量淨額 | (198,153) | (231,317) | (335,936) | (289,211) | (556,377) |
| 籌資活動產生之現金流量淨額 | 260,600 | (103,506) | (93,745) | 38,237 | 148,460 |
| 匯率變動對現金及現金等價物的影響 | (62) | 49 | (28) | (23) | (1,190) |
| 現金及現金等價物淨增加/(減少) | (21,488) | (550,764) | (107,918) | 428,009 | 115,112 |
| 期初現金及現金等價物餘額 | 769,597 | 1,320,361 | 1,428,279 | 1,000,271 | 885,158 |
| 期末現金及現金等價物餘額 | 748,109 | 769,597 | 1,320,361 | 1,428,279 | 1,000,271 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 22/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
